Influenza Vaccine, Adjuvanted (Fluad)
Influenza Vaccine, Adjuvanted is an FDA-licensed reference biologic from Seqirus Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2015
Reference approved
Reference product
Fluad Influenza Vaccine, Adjuvanted
Seqirus Inc.
- Approved
- Nov 24, 2015
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Influenza Vaccine, Adjuvanted, in chronological order.
Reference approval
Approval date of the reference Influenza Vaccine, Adjuvanted product.
10 yr 8 mo ago
Frequently asked questions
Are there biosimilars approved for Influenza Vaccine, Adjuvanted (Fluad)?
No 351(k) biosimilars or interchangeable biosimilars referencing Influenza Vaccine, Adjuvanted are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.